<?xml version="1.0" encoding="UTF-8"?>
<p>Recent studies utilizing gene knockdown techniques and small molecule inhibitors have shown that HO-1 induction suppresses development of metabolic disorders and nerve system disorders including obesity [
 <xref rid="B8-antioxidants-09-01191" ref-type="bibr">8</xref>], hypertension [
 <xref rid="B9-antioxidants-09-01191" ref-type="bibr">9</xref>], atherosclerosis [
 <xref rid="B10-antioxidants-09-01191" ref-type="bibr">10</xref>], Parkinsonâ€™s disease [
 <xref rid="B11-antioxidants-09-01191" ref-type="bibr">11</xref>] and hepatic fibrosis [
 <xref rid="B12-antioxidants-09-01191" ref-type="bibr">12</xref>]. A significant body of literature has focused on the mechanism of heme degradation by HO-1 and there is strong evidence that inducing HO-1 expression is an effective method of suppressing oxidative dysregulation, inadequate immune response and related disorders [
 <xref rid="B13-antioxidants-09-01191" ref-type="bibr">13</xref>].
</p>
